As Chief Technology Officer at Myriad Genetics, Kevin Haas, Ph.D leads the development of the precision medicine platform, including the company’s patient/provider digital experience and advanced genomics, harnessing genetic data and powering breakthrough products to serve millions of customers. Kevin joined Myriad in May 2013, serving previously as senior vice president of technology and senior vice president of engineering at Myriad, as well as vice president of bioinformatics at Myriad Women's Health. He previously served on the Board of Directors and as Vice President for USA Triathlon, the non-profit national governing body for the sport.
He received a B.S. from University of Wisconsin-Madison and a Ph.D. in Chemical Engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics from single molecule fluoresce. He has co-authored 16 peer reviewed publications and nine patent applications.
By fostering collaboration and seamless data integration into healthcare systems, the industry is laying the groundwork for a future in which “personalized medicine” is so commonplace within clinical practice that we will just start calling it “medicine.”